Syner-G Employee Directory
Pharmaceutical ManufacturingMassachusetts, United States201-500 Employees
Syner-G BioPharma Group serves as a Strategic Development & Delivery Partner to biopharma innovators, offering integrated guidance across scientific, regulatory, technical, and strategic aspects of the development lifecycle. With a global team spanning North America, Europe, and APAC, it collaborates with clients to navigate the complexity of development and commercialization, aiming to reduce risk and accelerate progress. The firm covers IND-to-NDA milestones by combining scientific rigor with operational excellence to advance therapies that improve patient lives. Headquartered in Framingham, Massachusetts, the company is a mid-sized, globally distributed organization that has grown through a 2024 merger with Sequoia Biotech and a 2023 acquisition of RMC Pharmaceutical Solutions. In June 2026, Syner-G launched 3D Intelligence (3Di), a people-centered AI transformation service for the biopharma development lifecycle.